Viagra Patent Remains In Limbo In China
More than two years after China granted patent exclusivity for Pfizer's Viagra anti-impotence drug, an onslaught of patent challenges has left the drug's status in limbo, officials at China's State Intellectual...To view the full article, register now.
Already a subscriber? Click here to view full article